Scott Ganz is a research fellow in economic policy at the American Enterprise Institute. He is also an associate teaching professor of strategy at the McDonough School of Business at Georgetown University. From 2009 to 2011, he was special assistant to the vice chairman on the Financial Crisis Inquiry Commission.
The clamor for its approval is understandable, but there are good reasons to ensure that it is effective enough.
The preliminary results provided reason for optimism, but left many questions unanswered.
The FDA’s emphasis on safety means a vaccine is months away, but we can learn before that how well they work against the virus.
As companies rush to try to make needed ventilators, it’s worth revisiting efforts to make more airplanes in World War II.